Reishi (Ganoderma lucidum)

Reishi (Ganoderma lucidum), known in Chinese medicine as Lingzhi or 'the mushroom of immortality,' is the archetype of the modern adaptogen: a substance that non-specifically enhances the body's resistance to biological, chemical, and psychological stressors without disrupting normal function. Its active compounds are among the most extensively studied in the functional mushroom world — over 400 distinct bioactive molecules have been identified, including more than 140 triterpenoids (ganoderic acids A through Z and beyond), beta-glucans, proteoglycans, and small immunomodulatory proteins. The ganoderic acids are Reishi's most pharmacologically distinctive compounds. They act on the hypothalamic-pituitary-adrenal (HPA) axis — the central stress response system — suppressing excessive cortisol and epinephrine release through modulation of CRH and ACTH signaling. A dose-response study in college students demonstrated that 1,000 mg daily significantly outperformed both 500 mg and placebo for anxiety and depression reduction within 30 days. A 2024 randomized trial confirmed reduced fatigue, anxiety, and depression in cancer patients receiving Reishi alongside standard therapy. The 2026 Wiley Brain and Behavior RCT examined adaptogenic mushroom blends (including Reishi) for stress, fatigue, and sleep in a double-blind placebo-controlled design. For sleep, Reishi's triterpenes increase non-REM sleep time and reduce sleep onset latency in animal models; human sleep-specific trials remain limited but consistent with this mechanism. The Memorial Sloan Kettering Cancer Center lists Reishi as demonstrating 'anti-tumor, immunostimulant, and chemoprotective' activities based on the clinical and preclinical record. Ganoderic acid shows anti-proliferative activity in 26 human cancer cell types across laboratory studies. Host Defense Reishi, produced by mycologist Paul Stamets' Fungi Perfecti and priced at approximately $29.99 for 60 capsules (500 mg each), is the category's most recognizable and trusted brand. Dosing typically ranges from 1,000–5,000 mg of dried mushroom equivalent daily, with concentrated extracts effective at lower absolute weights. Safety is well-established; the primary drug interactions involve anticoagulants and blood pressure medications.